Daisy Xu
Investitore di Private Equity presso Vivo Capital LLC
Provenienza dei contatti di primo grado di Daisy Xu
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Vivo Capital LLC
 Vivo Capital LLC Investment ManagersFinance Vivo Capital LLC (Vivo Capital) is a venture capital firm founded in 1996 by Frank C. Kung and Edgar G. Engleman. The firm is headquartered in Palo Alto, California.
55
| Private Company | Investment Managers | 55 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Daisy Xu tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| MORGAN STANLEY | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Pharmaceuticals: Major | Founder Chief Executive Officer | |
| ARROWHEAD PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| Rochester Christian University | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Crown Bioscience, Inc.
 Crown Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Crown Bioscience, Inc. provides biomedical outsourcing solutions. It provides syngeneic and xenograft tumor models and custom model development and drug testing. The firm produces antibodies for therapeutic, diagnostic and theranostic applications. It also offers preclinical and drug development for anti-cancers therapeutics. The company was founded by Dr. Yiyou Chen, Dr. Yue Alexander Wu, Dr. William Pan and Dr. Faming Zhang in 2006 and is headquartered in Santa Clara, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| SOLENO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
Semnur Pharmaceuticals, Inc.
 Semnur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Semnur Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The firm focuses on the clinical and commercial development of products such as SP-102: a non-opioid epidural steroid injectable potentially for the treatment of Lumbosacral radicular pain. The company was founded by Mahendra G. Shah in 2013 and is headquartered in Mountain View, CA. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member | |
SCILEX Pharmaceuticals, Inc.
 SCILEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SCILEX Pharmaceuticals, Inc. engages in the development and commercialization of pharmaceutical products. It acquires late-stage clinical development and sales and marketing of generic and branded generic products. Its product includes ZTlido. The company was founded by Anthony P. Mack and William Pedranti in 2011 and is headquartered in Berwyn, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
| Stanford University | College/University | Undergraduate Degree Graduate Degree | |
Surgical Specialties Corp.
 Surgical Specialties Corp. Medical SpecialtiesHealth Technology Surgical Specialties Corp. manufactures medical products. It specializes in designing and manufacturing of surgical knives and wound closure products. The firm offers suture needles, sutures, microsurgical cutting instruments, eye garters, and ophthalmic cannulas. The company is headquartered in Westwood, MA. | Medical Specialties | Chairman Chief Executive Officer | |
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree Graduate Degree Masters Business Admin Undergraduate Degree | |
| Tsinghua University | College/University | Undergraduate Degree Graduate Degree | |
| Sichuan University | College/University | Undergraduate Degree Undergraduate Degree | |
| Fudan University | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
Neomend, Inc.
 Neomend, Inc. BiotechnologyHealth Technology Neomend, Inc. develops surgical wound healing products. It offers adhesion prevention products for hospitals and medical facilities. The company was founded in 1999 and is headquartered in Irvine, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| SAGENT PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
MacuLogix, Inc.
 MacuLogix, Inc. Medical/Nursing ServicesHealth Services MacuLogix, Inc. engages in the early detection and tracking of retinal diseases. Its AdaptDx is the first practical measurement tool for dark adaptation which provides doctors with an easy-to-use functional test similar to routine perimetry testing for glaucoma. The company also provides macular degeneration services. The company was founded by John G. Edwards and Gregory R. Jackson in 2004 and is headquartered in Harrisburg, PA. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO.,LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| TOT BIOPHARM INTERNATIONAL COMPANY LIMITED | Pharmaceuticals: Major | Director/Board Member Chairman | |
| Stanford Graduate School of Business | College/University | Masters Business Admin Masters Business Admin | |
| Columbia University College of Physicians & Surgeons | College/University | Doctorate Degree Doctorate Degree | |
| Tarsus China Ltd. | Director/Board Member | ||
| BOLT BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
| CRINETICS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Medeor Therapeutics, Inc.
 Medeor Therapeutics, Inc. Medical/Nursing ServicesHealth Services Medeor Therapeutics, Inc. engages in medical industry. It provides services which are dedicated to the discovery, development, and commercialization of transformative and personalized cellular therapeutics. The company was founded by Samuel Strober, Edgar Engleman, Robert Lowsky, and Chih Ping in 2012 and is headquartered in South San Francisco, CA. | Medical/Nursing Services | Founder Director/Board Member | |
Artios Pharma Ltd.
 Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Artios Pharma Ltd. manufactures pharmaceutical products. The firm develops a DNA Damage Response (DDR) is a cancer therapy. The company was founded by Niall Martin in May 2016 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Arbor Biotechnologies, Inc.
 Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Arbor Biotechnologies, Inc. engages in curating genetic biodiversity and discover novel protein functions from nature. The company was founded by David Arthur Svott, Winston Xia Yan, Feng Zhang and David R. Walt in 2016 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| INNOCARE PHARMA LIMITED | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PASSAGE BIO, INC. | Biotechnology | Director/Board Member | |
| Stanford School of Medicine | College/University | Doctorate Degree | |
| STRUCTURE THERAPEUTICS INC. | Miscellaneous Commercial Services | Director/Board Member | |
German Medical Technology Co., Ltd.
 German Medical Technology Co., Ltd. Medical SpecialtiesHealth Technology German Medical Technology Co., Ltd. develops, manufactures, and sells disposable and implantable medical devices. | Medical Specialties | Director/Board Member | |
VISEN Pharmaceuticals (Shanghai) Co., Ltd.
 VISEN Pharmaceuticals (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology VISEN Pharmaceuticals (Shanghai) Co., Ltd. is a Chinese pharmaceutical company that focuses on the development of products and technology for endocrine diseases. The company is based in Shanghai, China, and the CEO of the company is An Bang Lu. The company has developed a product called Long Pei, which is the first American FDA-approved growth hormone that can be released within a week to deliver growth hormone. VISEN Pharmaceuticals has also entered into a strategic cooperation agreement with Peking University Clinical Research Institute to carry out clinical research on thyroid dysfunction. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Shanghai ShouTi Biotechnology Co., Ltd.
 Shanghai ShouTi Biotechnology Co., Ltd. BiotechnologyHealth Technology Part of Structure Therapeutics, Inc., Shanghai ShouTi Biotechnology Co., Ltd. develops biotechnologies. The company is based in Shanghai, China. The CEO of the Chinese company is Xi Chen Lin. | Biotechnology | Director/Board Member | |
Shanghai Rarestone Health Tech Group Co. Ltd.
 Shanghai Rarestone Health Tech Group Co. Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Rarestone Health Tech Group Co. Ltd. is a Chinese company that focuses on rare disease therapy and self-management information through internet information. The company is based in Huangpu, China. The company also operates and promote medical devices and communication platforms. The CEO of the company is Shawn Xiang. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder | |
| Vivo Co-Invest (S) LP | Director/Board Member Director/Board Member Director/Board Member | ||
Upstream Bio, Inc.
 Upstream Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Upstream Bio, Inc. is a clinical-stage biopharmaceutical company based in Waltham, MA, USA. The American company's lead program, upb-101, is a monoclonal antibody that inhibits the TSLP receptor, a validated target that affects various immune cells involved in common and rare diseases. Upstream Bio is leveraging its diverse roots and substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones. The company was founded by Eran Perry and Earn Perry, and Samantha Truex has been the CEO since 2021. | Miscellaneous Commercial Services | Director/Board Member | |
VISEN Pharmaceuticals
 VISEN Pharmaceuticals BiotechnologyHealth Technology VISEN Pharmaceuticals operates as a biopharmaceutical company. It focuses on developing therapies and patient-centric care on endocrine diseases. The firm operates a segment which is developing and commercializing paradigm-shifting endocrine therapies in Greater China. The company was founded on November 1, 2018 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| Jian Rui Bao | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 36 |
| Cina | 13 |
| Hong Kong | 2 |
| Regno Unito | 2 |
| Isole Cayman | 2 |
Settori
| Health Technology | 30 |
| Consumer Services | 13 |
| Commercial Services | 4 |
| Health Services | 3 |
| Finance | 2 |
Posizioni
| Director/Board Member | 212 |
| Private Equity Investor | 50 |
| Independent Dir/Board Member | 45 |
| Corporate Officer/Principal | 43 |
| Undergraduate Degree | 36 |
Contatti più connessi
| Insiders | |
|---|---|
| Jack Nielsen | 38 |
| Mahendra Shah | 34 |
| Chen-Ming Yu | 33 |
| Albert Cha | 30 |
| Edgar Engleman | 29 |
| Hong Bo Lu | 28 |
| Frank Kung | 22 |
| Gaurav Aggarwal | 21 |
| Scott Whitcup | 18 |
| Shan Fu | 17 |
| Mitchell Mutz | 16 |
| Joseph Siletto | 12 |
| Sean Lo | 9 |
| Yuh-Geng Tsay | 8 |
| Dan Dan Dong | 8 |
- Borsa valori
- Insiders
- Daisy Xu
- Connessioni Società
